Novartis wins US OK for biosimilar version of Amgen’s Enbrel Aug 30th

How to go about securing the best policy for your insurance in Canada.
Latest News
 insurance rates

Choosing a Group Benefits Advisor Mar 28th

How Getting a Group Benefits Plan Works A company that is looking for a benefits plan engages an advisor (e.g. a broker or agent) who then submits that company’s details to several insurance companies for a quote. (An experienced advisor will know which insurance companies are best suited for.... More »

Compare high-risk auto insurance quotes for Ontario Feb 8th

The cost of auto insurance—which is required for drivers in Canada—can vary widely. Why? Because it’s all about risk. How risky your car is—is it prone to safety issues that could cause an accident? Is it a car-thief magnet? How risky your neighbourhood is—whether you live in an urban or r.... More »
 car insurance

How to qualify for EI benefits in retirement Mar 27th

Q: I’m a 75-year old male, working part-time and contributing to EI every 2 weeks; and have been for 10 years. I do have CPP and OAS income. Do I qualify to collect EI benefits for a period of time if I retire this year? I’ve paid contributions for 10 years and now plan to retire so I shou.... More »
 insurance quote

How Much Life Insurance is Enough? + MORE Mar 11th

A commonly asked question regarding life insurance is “how much life insurance is enough?” Simply put: the amount of coverage needed depends on the amount of debt and income loss the plan has to cover. This is determined by the total assets that can be allocated subtracted from the amoun.... More »
 car insurance

The Benefits of Donating a Life Insurance Policy to Charity + MORE May 7th

Life insurance policies cannot only be left to an individual beneficiary, but can be donated to charity. Along with the satisfaction of knowing that you are leaving money to a worthy cause, donating your policy will also have certain tax benefits. Donating your life insurance policy can be accompli.... More »
U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen’s pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders.
The follow-up version of Enbrel, dubbed Erelzi, was developed by Swiss drug giant Novartis, which would not disclose the planned list price for Erelzi.
Novartis also couldn’t say when the new medicine will be launched by its Sandoz unit, which makes generic drugs and “biosimilars” — nearly identical versions of biologic drugs produced in living cells.
Erelzi is the third biosimilar drug approved by the Food and Drug Administration. It’s also the second approved biosimilar developed by Novartis, and the second that will compete with an Amgen drug.
Enbrel was first approved in 1998. It can cost about $4,000 per month without insurance.
The post Novartis wins US OK for biosimilar version of Amgen’s Enbrel appeared first on Canadian Business – Your Source For Business News.

Continue Reading On canadianbusiness.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!